Andre Cohnen

Title: The Innovations of Andre Cohnen

Introduction

Andre Cohnen is a notable inventor based in Munich, Germany. He has made significant contributions to the field of genetic engineering, particularly in the development of RNA-programmable endonuclease systems. With a total of 2 patents, his work is paving the way for advancements in genome editing technologies.

Latest Patents

Cohnen's latest patents include "RNA-programmable endonuclease systems and uses thereof." This invention focuses on novel systems for targeting, editing, or manipulating DNA within a cell, utilizing synthetic RNA-guided nucleases (sRGNs) derived from small type II CRISPR Cas9 endonucleases. Another patent, "RNA-programmable endonuclease systems and their use in genome editing and other applications," also emphasizes innovative systems for DNA manipulation, incorporating heterologous vectors encoding SluCas9 nucleases and guide RNAs (gRNAs).

Career Highlights

Throughout his career, Andre Cohnen has worked with prominent companies such as Bayer Healthcare LLC and Crispr Therapeutics AG. His experience in these organizations has allowed him to refine his expertise in genetic technologies and contribute to groundbreaking research.

Collaborations

Cohnen has collaborated with notable colleagues, including Moritz Schmidt and Wayne Coco. Their combined efforts have further advanced the field of genetic engineering and contributed to the success of their projects.

Conclusion

Andre Cohnen's innovative work in RNA-programmable endonuclease systems showcases his commitment to advancing genetic engineering. His patents and collaborations reflect a dedication to improving genome editing technologies, which may have far-reaching implications for various applications in science and medicine.